| 5MT | 5-methoxytryptamine |
| AANAT | Aralkylamine N-acetyltransferase |
| AD | Atopic dermatitis |
| AFMK | N1-acetyl-N2-formyl-5-methoxykynuramine |
| AMK | N1-acetyl-5-methoxykynuramine |
| aMT | N-acetyl-5-methoxytryptamine, melatonin |
| AP-1 | Activator protein-1 |
| ASMT | Acetylserotonin O-methyltransferase |
| CAT | Catalase |
| CRP | C-reactive porotein |
| COX-2 | Cyclooxygenase-2 |
| ETC | Electron transport chain |
| FGF-β | Fibroblast growth factor-β |
| GLI1 | Glioma-associated oncogene transcription factor |
| GPx | Glutathione peroxidase |
| GRd | Glutathione reductase |
| GST | Glutathionine S-transferase |
| HH | Hedgehog pathway |
| HO-1 | Heme oxygenase-1 |
| IFN-γ | Interferon type II (IFN-γ in humans) |
| ILs | Interleukins |
| iNOS | Inducible nitric oxide synthase |
| MAPKs | Mitogen-activated protein kinases |
| MDA | Malondialdehyde |
| MMPs | Metalloproteinases |
| MPTP | Mitochondrial permeability transition pores |
| MT1 | Membrane receptors type I |
| MT2 | Membrane receptors type II |
| MT3 | Membrane receptors type III |
| mtNOS | Mitochondrial nitric oxide synthase |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLCs | Nanostructured lipid carriers |
| NQO1 | NAD(P)H dehydrogenase [quinone] 1 |
| NQO2 | NAD(P)H dehydrogenase [quinone] 2, flavoprotein quinone oxidoreductase II |
| Nrf2 | Nuclear factor erythroid-2-related factor 2 |
| RNS | Reactive nitrogen species |
| RORα | Retinoic acid related orphan receptor alfa |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| γ-GCS | γ-glutamyl-cystein synthase |